Cerebellum (in blue) of the human brain
Find information on thousands of medical conditions and prescription drugs.

Cerebellar ataxia

Spinocerebellar ataxia (SCA) is a genetic disease with multiple types, each of which could be considered a disease in its own right. As with other forms of ataxia, SCA results in unsteady and clumsy motion of the body due to a failure of the fine coordination of muscle movements, along with other symptoms. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

It can be easily misdiagnosed as another neurological condition, such as multiple sclerosis (MS). There is no known cure for this degenerative condition, which lasts for the remainder of the sufferer's life. Treatments are generally limited to softening symptoms, not the disease itself. The condition is irreversible. A person with this disease will usually end up needing to use a wheelchair, and eventually they will need assistance to perform daily tasks. The symptoms of the condition vary with the specific type (there are several), and with the individual patient. Generally, a sufferer retains full mental capacity while they progressively lose physical control over their body until their death.

One means of identifying the disease is with an MRI to view the brain. Once the disease has progressed sufficiently, the cerebellum (a part of the brain) can be seen to have visibly shrunk. The most precise means of identifying SCA, including the specific type, is through DNA analysis. Some, but far from all, types of SCA may be inherited, so a DNA test may be done on the children of a sufferer, to see if they are at risk of developing the condition.

SCA is related to olivopontocerebellar atrophy (OPCA); SCA types 1, 2, and 7 are also types of OPCA. However, not all types of OPCA are types of SCA, and vice versa. This overlapping classification system is both confusing and controversial to some in this field.

Types

The following is a list of some, not all, types of Spinocerebellar ataxia. The first ataxia gene was identified in 1993 for a dominantly inherited type. It was called “Spinocerebellar ataxia type 1" (SCA1). Subsequently, as additional dominant genes were found they were called SCA2, SCA3, etc. Usually, the "type" number of "SCA" refers to the order in which the gene was found. At this time, there are at least 22 different gene mutations which have been found (not all listed).

Identifying the different types of SCA now requires knowledge of the normal genetic code, and faults in this code, which are contained in a person's DNA (Deoxyribonucleic acid). The "CAG" mentioned below is one of many three-letter sequences that makes up the genetic code, this specific one coding the aminoacid glutamine. Thus, those ataxias with poly CAG expansions, along with several other neurodegenerative diseases resulting from a poly CAG expansion, are referred to as polyglutamine diseases.

Notes

Both onset of initial symptoms and duration of disease can be subject to variation. If the disease is caused by a polyglutamine trinucleotide repeat CAG expansion, a longer expansion will lead to an earlier onset and a more radical progression of clinical symptoms, resulting in earlier death.

Read more at Wikipedia.org


[List your site here Free!]


Heart block associated with spinocerebellar ataxia type 2
From Military Medicine, 9/1/02 by Riggs, Jack E

A 20-year-old man was discharged from the U.S. Army because of increasing gait abnormalities. One year later, he developed episodes of syncope secondary to high-degree atrial/ventricular block with periods of complete heart block and ventricular asystole. A permanent dual-chamber, rate-responsive cardiac pacemaker was implanted. At age 29 years, an abnormal expansion of the CAG trinucleotide repeat in the ataxin-2 gene on chromosome 12 was identified. This case suggests that cardiac conduction abnormalities should be included as part of the recognized clinical heterogeneity of spinocerebellar ataxia type 2.

Introduction

Spinocerebellar ataxia type 2 (SCA2) is one of several polyglutamine expansion neurodegenerative disorders and is caused by an expansion of an unstable CAG trinucleotide repeat located in the ataxin-2 gene on chromosome 12.1 Cardiac conduction abnormalities have not been previously associated with SCA2.

Case Report

A 22-year-old man was referred for evaluation of "olivopontocerebellar degeneration." There was no family history of neurologic disease. His early development was described as normal. The patient did very well academically in school until age 12 years, when his grades began to decrease and his handwriting became sloppy. Despite some clumsiness, he entered the U.S. Army after graduating from high school. Because of increasing gait problems, he was evaluated at Tripler Army Medical Center at age 20 years. Computed tomography and magnetic resonance imaging scans demonstrated cerebellar and brainstem atrophy. He was also found to be hypothyroid and was started on treatment with levothyroxine. At age 21 years, he began to experience recurrent episodes of syncope that were found to be secondary to high-degree atrial/ventricular block with periods of complete heart block and ventricular asystole. Echocardiography demonstrated normal valves and left ventricular function. A permanent dualchamber, rate-responsive cardiac pacemaker was implanted.

On examination, the patient had scanning speech, slow saccades of eye movements, inability to tandem walk, moderate dysmetria, and absent muscle stretch reflexes. His neurologic examination was otherwise unremarkable.

Over the next several years, his ataxia increased to the point that he became wheelchair dependent for mobility. At age 29 years, an abnormal expansion of the CAG trinucleotide repeat in the ataxin-2 gene on chromosome 12 was identified (44 repeats on allele 1 and 22 repeats on allele 2; normal is less than 31 repeats [Athena Diagnostics, Worcester, Massachusetts]). A diagnosis of spinocerebellar ataxia type 2 was established.

Discussion

Although the clinical heterogeneity of SCA2 is well recognized,2-5 associated cardiac conduction abnormalities have not been described. The frequent association of cardiomyopathy and/or cardiac conduction abnormalities in other neurodegenerative diseases caused by abnormal expansion of trinucleotide repeats (such as myotonic dystrophy6 and Friedreich's ataxia7) and the observation that the ataxin-2 protein is present in human heart8 suggests that cardiac conduction abnormalities in SCA2 are also representative of the clinical heterogeneity of SCA2 rather than just a coincidental observation.

References

1. Imbert G. Saudou F, Yvert G, et al: Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996; 14: 285-6.

2. Fila A, De Michele G, Banfi S, et al: Has spinocerebellar ataxia type 2 a distinct phenotype? Genetic and clinical study of an Italian family. Neurology 1995; 45: 796.

3. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM: The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 1997; 60: 842-50.

4. Fernandez M, McClain ME, Martinez RA, et al: Late-onset SCA2: 33 repeats are sufficient to cause disease. Neurology 2000: 55: 569-72.

5. Gwinn-Hardy K, Chen JY, Liu H-C, et at: Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000; 55: 800-5.

6. Clarke NR, Kelion AD, Nixon J, Hilton-Jones D, Forfar JC: Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 2001: 86: 411-6.

7. Bit-Avragim N, Perrot A, Schols L, et al: The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia. J Mol Med 2001: 78: 626-32.

8. Affaitati A, de Cristofaro T, Feliciello A, Varrone S: Identification of alternative splicing of spinocerebellar ataxia type 2 gene. Gene 2001; 267: 89-93.

Guarantor: CAPT Jack E. Riggs, MC USNR

Contributor: CAPT Jack E. Riggs, MC USNR

Departments of Neurology, Medicine, and Community Medicine, West Virginia University School of Medicine, Morgantown, WV 26506-9180.

The opinions and assertions contained herein are those of the author and do not necessarily reflect those of the Navy Medical Department or the Department of Defense.

This manuscript was received for review in October 2001 and was accepted for publication in March 2002.

Copyright Association of Military Surgeons of the United States Sep 2002
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Cerebellar ataxia
Home Contact Resources Exchange Links ebay